Optimization of a new adaptive intervention using the SMART Design to increase COVID-19 testing among people at high risk in an urban community

Liliane Windsor, Ellen Benoit, Rogério M Pinto, Jesus Sarol, Liliane Windsor, Ellen Benoit, Rogério M Pinto, Jesus Sarol

Abstract

Background: COVID-19 has impacted the health and social fabric of individuals and families living across the USA, and it has disproportionately affected people living in urban communities with co-morbidities, those working in high-risk settings, refusing or unable to adhere to CDC guidelines, and more. Social determinants of health (SDH), such as stigmatization, incarceration, and poverty, have been associated with increased exposure to COVID-19 and increased deaths. While vaccines and booster shots are available, it will take time to reach herd immunity, and it is unclear how long newly developed vaccines provide protection and how effective they are against emerging variants. Therefore, prevention methods recommended by the Centers for Disease and Control (CDC)-i.e., testing, hand-washing, social distancing, contact tracing, vaccination and booster shots, and quarantine-are essential to reduce the rates of COVID-19 in marginalized communities. This project will adapt and test evidence-based HIV interventions along the prevention and treatment cascade to help address COVID-19 prevention needs.

Methods: The study aims to (1) optimize an adaptive intervention that will increase rates of testing and adherence to New Jersey State COVID-19 recommendations (testing, social distancing, quarantine, hospitalization, contact tracing, and acceptance of COVID-19 vaccination and booster shots) among high-risk populations and (2) identify predictors of testing completion and adherence to New Jersey recommendations. This study follows Community Based Participatory Research (CBPR) principles to conduct a Sequential, Multiple Assignment Randomized Trial (SMART) with 670 COVID-19 medically/socially vulnerable people. Participants will be recruited using a variety of strategies including advertisements on social media, posting fliers in public places, street outreach, facility-based, and snowball sampling. Participants complete a baseline survey and are randomized to receive navigation services or an electronic brochure. They then complete a follow-up 7 days after baseline and are randomized again to either continue with their original assignment or switch to the other intervention or critical dialog or brief counseling. Participants then complete a 5-week post-baseline follow-up. Guided by the COVID-19 Continuum of Prevention, Care, and Treatment, the analysis will explore the factors associated with COVID-19 testing within 7 days of the intervention.

Discussion: This paper describes the protocol of the first study to use SMART following CBPR to adapt evidence-based HIV prevention interventions to COVID-19. The findings will inform the development of an effective and scalable adaptive intervention to increase COVID-19 testing and adherence to public health recommendations, including vaccination and booster shots, among a marginalized and difficult-to-engage population.

Trial registration: ClinicalTrials.gov NCT04757298 . Registered on February 17, 2021.

Keywords: Brief counseling; COVID-19 testing; COVID-19 treatment cascade; Critical dialog; Navigation services; Sequential Multiple Assignment Randomized Trials (SMART).

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Trial design

References

    1. Marrett CB. Racial disparities and COVID-19: the social context. J Racial Ethn Health Disparities. 2021;8(3):794–7.
    1. Centers for Disease Control. Coronavirus disease 2019 (COVID-19). Available from:
    1. Rollston R, Galea S. COVID-19 and the social determinants of health. Am J Health Promot. 2020;34(6):687–689. doi: 10.1177/0890117120930536b.
    1. Kirby T. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities. Lancet Respir Med. 2020;8(6):547–8.
    1. Badiani AA, Patel JA, Ziolkowski K, Nielsen FBH. Pfizer: the miracle vaccine for COVID-19? Public health in practice. 2020. p. 100061.
    1. Center for Disease Control . Prevent getting sick. 2021.
    1. Jaiswal J, LoSchiavo C, Perlman DC. Disinformation, misinformation and inequality-driven mistrust in the time of COVID-19: lessons unlearned from AIDS denialism. AIDS Behav. 2020;24(10):1. doi: 10.1007/s10461-020-02925-y.
    1. Pinto RM, Park S. COVID-19 pandemic disrupts HIV continuum of care and prevention: implications for research and practice concerning community-based organizations and frontline providers. AIDS Behav. 2020;24(9):1. doi: 10.1007/s10461-020-02893-3.
    1. Owen WF, Carmona R, Pomeroy C. Failing another national stress test on health disparities. JAMA American Medical Association. 2020;323(19):1905–1906. doi: 10.1001/jama.2020.6547.
    1. Agyemang C, Richters A, Jolani S, Hendriks S, Zalpuri S, Yu E, et al. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis. BMJ Glob Health. 2021;6(11):e007433. doi: 10.1136/bmjgh-2021-007433.
    1. Farmer B. Racial bias showing up in coronavirus testing and treatment: shots - health news [Internet]. National Public Radio. 2020; Available from: .
    1. Wallace CL, Wladkowski SP, Gibson A, White P. Grief during the COVID-19 pandemic: considerations for palliative care providers. J Pain Symptom Manag. 2020;60(1):e70–e76. doi: 10.1016/j.jpainsymman.2020.04.012.
    1. Ammerman BA, Burke TA, Jacobucci R, McClure K. Preliminary investigation of the association between COVID-19 and suicidal thoughts and behaviors in the U.S. J Psychiatr Res. 2021;134:32–38. doi: 10.1016/j.jpsychires.2020.12.037.
    1. Pfefferbaum B, North CS. Mental health and the COVID-19 pandemic. New Engl J Med. 2020;383(6):510–512. doi: 10.1056/NEJMp2008017.
    1. Wohl AR, Dierst-Davies R, Victoroff A, James S, Bendetson J, Bailey J, Daar E, Spencer LS, Kulkarni S, Pérez MJ. Implementation and operational research: the navigation program: an intervention to reengage lost patients at 7 HIV clinics in Los Angeles County, 2012-2014. J Acquir Immune Defic Syndr. 1999;2016(2):71(2)–71e50. doi: 10.1097/QAI.0000000000000871.
    1. Ruzagira E, Grosskurth H, Kamali A, Baisley K. Brief counselling after home-based HIV counselling and testing strongly increases linkage to care: a cluster-randomized trial in Uganda. J Int AIDS Soc. 2017;20(2) Available from: . [cited 2021 Dec 5].
    1. Windsor L, Jessell L, Lassiter T, Benoit E. Community wise: a formative evaluation of a community based health intervention. Int Public Health J. 2015;7(1):501–11.
    1. Medland NA, McMahon JH, Chow EPF, Elliott JH, Hoy JF, Fairley CK. The HIV care cascade: a systematic review of data sources, methodology and comparability. J Int AIDS Soc. 2015;18(1):20634. 10.7448/IAS.18.1.20634.
    1. West R, Michie S, Rubin GJ, Amlôt R. Applying principles of behaviour change to reduce SARS-CoV-2 transmission. Nat Hum Behav Nature Research. 2020;4:451–459. doi: 10.1038/s41562-020-0887-9.
    1. Israel B, Schultz A, Parker E, Becker A, Allen A, Guzman R. In: Critical issues in developing and following community based participatory research principles. Minkler M, Wallwestein N, Hall B, editors. New York: Thousand Oaks; 1998. pp. 47–67.
    1. Collins LM. Optimization of behavioral, biobehavioral, and biomedical interventions: the Multiphase Optimization Strategy (MOST) 1. Switzerland: Springer International Publishing; 2018. p. 297.
    1. Kidwell KM, Seewald NJ, Tran Q, Kasari C, Almirall D. Design and analysis considerations for comparing dynamic treatment regimens with binary outcomes from sequential multiple assignment randomized trials. J Appl Stat. 2018;45(9):1628–1651. doi: 10.1080/02664763.2017.1386773.
    1. Viswanathan M, Ammerman A, Eng E, Gartlehner G, Lohr KN, Griffith D, et al. Community-based participatory research: assessing the evidence. 2004.
    1. Windsor LC, Benoit E, Smith D, Pinto RM, Kugler KC. Optimizing a community-engaged multi-level group intervention to reduce substance use: an application of the multiphase optimization strategy. Trials. 2018;19(1):225.
    1. Windsor LC. Using concept mapping in community-based participatory research: a mixed methods approach. J Mixed Methods Res. 2013;7(3):274–93.
    1. The State of New Jersey. New Jersey COVID-19 Information Hub. Available from:
    1. McElfish PA, Purvis R, James LP, Willis DE, Andersen JA. Perceived barriers to covid-19 testing. Int J Environ Res Public Health. 2021;18(5):2278. 10.3390/ijerph18052278.
    1. Earnshaw VA, Brousseau NM, Hill EC, Kalichman SC, Eaton LA, Fox AB. Anticipated stigma, stereotypes, and COVID-19 testing. Stigma Health. 2020;5(4):390–3.
    1. Hu T, Yue H, Wang C, She B, Ye X, Liu R, et al. Racial segregation, testing site access, and COVID-19 incidence rate in Massachusetts, USA. Int J Environ Res Public Health. 2020;17(24):9528. 10.3390/ijerph17249528.
    1. Oates GR, Juarez LD, Horswell R, Chu S, Miele L, Fouad MN, Curry WA, Fort D, Hillegass WB, Danos DM. The association between neighborhood social vulnerability and COVID-19 testing, positivity, and incidence in Alabama and Louisiana. J Commun Health. 2021;46(6):1115–1123. doi: 10.1007/s10900-021-00998-x.
    1. Jaspal R, Breakwell GM. Social support, perceived risk and the likelihood of COVID-19 testing and vaccination: cross-sectional data from the United Kingdom. Curr Psychol. 2021;41(1):492–504. doi: 10.1007/s12144-021-01681-z.
    1. Hamilton CM, Strader LC, Pratt JG, Maiese D, Hendershot T, Kwok RK, et al. The PhenX Toolkit: get the most from your measures. Am J Epidemiol. 2011;174(3):253–260. doi: 10.1093/aje/kwr193.
    1. NIH RADx-UP Common Data Elements - RADx-UP. [cited 2021 Dec 23]. Available from:
    1. Ali SH, Foreman J, Capasso A, Jones AM, Tozan Y, Diclemente RJ. Social media as a recruitment platform for a nationwide online survey of COVID-19 knowledge, beliefs, and practices in the United States: methodology and feasibility analysis. BMC Med Res Methodol. 2020;20(1) Available from: . [cited 2022 Jan 6].
    1. Cacciola JS, Alterman AI, Lynch KG, Martin JM, Beauchamp ML, McLellan AT. Initial reliability and validity studies of the revised Treatment Services Review (TSR-6) Drug Alcohol Depend. 2008;92(1–3):37–47. doi: 10.1016/j.drugalcdep.2007.06.004.
    1. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med (1982) 1991;32(6):705–714. doi: 10.1016/0277-9536(91)90150-B.
    1. Lang AJ, Stein MB. An abbreviated PTSD checklist for use as a screening instrument in primary care. Behav Res Ther. 2005;43(5):585–594. doi: 10.1016/j.brat.2004.04.005.
    1. Romppel M, Herrmann-Lingen C, Wachter R, Edelmann F, Düngen H-D, Pieske B, et al. A short form of the General Self-Efficacy Scale (GSE-6): development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure. Psychosoc Med. 2013;10:Doc01.
    1. Nahum-Shani I, Dziak JJ, Collins LM. Multilevel factorial designs with experiment-induced clustering. Psychol Methods. 2017; Available from: .
    1. Twisk J. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol. 2004;19(8):769–776. doi: 10.1023/B:EJEP.0000036572.00663.f2.
    1. Gilgun J. In: Grounded theory, analytic induction, and social work research. Reid W, Miller R, editors. New York: Columbia University Press; 2009.
    1. Crist JD, Tanner CA. Interpretation/analysis methods in hermeneutic interpretive phenomenology. Nurs Res. 2003;52(3):202–205. doi: 10.1097/00006199-200305000-00011.
    1. Shortreed SM, Laber L, Stroup TS, Pineau P, Murphy A. A multiple imputation strategy for sequential multiple assignment randomized trials. Stat Med. 2014;33(24):4202–4214. doi: 10.1002/sim.6223.
    1. Buuren S. GitHub - amices/mice: multivariate imputation by chained equations. Package Mice. 2021; Available from: . [cited 2022 Jan 6].
    1. Schafer J. . Multiple imputation for multivariate panel or clustered data. 2009 [cited 2022 Jan 6]. Available from:
    1. Mody A, Pfeifauf K, Bradley C, Fox B, Hlatshwayo MG, Ross W, Sanders-Thompson V, Joynt Maddox K, Reidhead M, Schootman M, Powderly WG, Geng EH. Understanding drivers of coronavirus disease 2019 (COVID-19) racial disparities: a population-level analysis of COVID-19 testing among Black and White populations. Clin Infect Dis. 2020;73(9):e2921–e2931. doi: 10.1093/cid/ciaa1848.
    1. Garnier R, Benetka JR, Kraemer J, Bansal S. Socioeconomic disparities in social distancing during the COVID-19 pandemic in the United States: observational study. J Med Internet Res. 2021;23(1):e24591. 10.2196/24591.
    1. Kirksey L, Tucker DL, Taylor E, Solaru KTW, Modlin CS. Pandemic superimposed on epidemic: COVID-19 disparities in Black Americans. J Natl Med Assoc. 2021;113:39–42.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera